Translation-X Moves Ahead with Venture Kick Stage 2 Success

Written By Ozgur Genc

We're excited to share that Translation-X has completed Stage 2 of Venture Kick. This milestone allows us to further our research in developing targeted treatments for autism spectrum disorders.

With the support from Venture Kick, we're moving forward in our drug development process. This progress is key to our project's growth and brings us closer to addressing the challenges of autism therapy. Read more

Ozgur Genc
Previous

Translation-X Secures full Venture Kick Support with a total of CHF 150,000 Funding
Next

Translation-X Presented at the 2nd Swiss RNA Therapeutics Summit